Study Title: A Phase 3, Open-Label, Randomized 2-arm Study Comparing the Clinical Efficacy and Safety of Niraparib With Temozolomide in Adult Participants With Newly Diagnosed, MGMT Unmethylated Glioblastoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Zukas, Alicia, at zukas@musc.edu.Study Coordinator, Newman, Eva, at newmanev@musc.edu.Trial opened at the following institutions: Medical University of South Carolina